About Us |
Contact Us |
LexisNexis Business Solutions
We’ve all seen what happens when due-diligence efforts fall short. In addition to tainting a company’s reputation, the bad actions of a third-party can lead to criminal investigations, hobbled business operations and hefty fines that impact a company for years. Wish you could see risk warning...
The regulatory environment that you operate in is more complex than ever—and as some of our past FCPA-focused blog posts show, organizations that fail to put due-diligence and third-party monitoring programs in place face enormous financial and reputational risks.
That’s why we’re...
Faced with increasing globalization and supply chain complexity, pharmaceutical companies have the daunting task of managing risks—ranging from counterfeiting to piracy—that could potentially threaten patient safety. What’s more, the pharmaceutical industry is not immune to the impact...
Last week, Mark Dunn, the due diligence segment leader for Risk and Compliance at LexisNexis, offered his insights during an ISM Webinar entitled “Mitigating Risks and Impact of Sanctions Regimes on Your Supply Chain.” It’s a growing area of concern, but as Kelly Barner noted in the...